E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/9/2006 in the Prospect News PIPE Daily.

New Issue: AspenBio Pharma raises additional $204,000, lifts private placement to $2.19 million

By Sheri Kasprzak

New York, May 9 - AspenBio Pharma, Inc. raised another $204,000 from its previously announced private placement for total proceeds of $2,192,000.

The company sold a total of 1,565,714 shares at $1.40 each.

On April 13, the company sold 1.42 million of the shares for proceeds of $1,988,000.

The proceeds will be used for product development, working capital and general corporate purposes.

Based in Castle Rock, Colo., AspenBio Pharma produces bovine pregnancy tests for the agricultural industry.

Issuer:AspenBio Pharma, Inc.
Issue:Stock
Amount:$2,192,000
Shares:1,565,714
Price:$1.40
Warrants:No
Settlement date:May 9
Stock symbol:OTCBB: APNB
Stock price:$1.72 at close May 8

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.